Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Jul 23 EFFECT Notice of effectiveness
- 13 Jul 23 424B3 Prospectus supplement
- 11 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
22 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 10 May 23 S-4 Registration of securities issued in business combination transactions
CRVO similar filings
Filing view
External links
Exhibit 99.3
DIRECTOR CONSENT
I hereby consent to serve as a director of Diffusion Pharmaceuticals Inc. (the “Company”), if elected as such, and to be named as a nominee or potential nominee for director of the Company in any registration statement filed by the Company under the Securities Act of 1933, as amended, including all amendments and post-effective amendments or supplements thereto and any prospectus and/or proxy statement contained therein.
/s/ Jeff Poulton | ||
Name: | Jeff Poulton | |
Date: | May 10, 2023 |